I guess the SEC was a little premature in suspending Artec in Dec. It seems that Artec's press releases and website were accurate in claiming the sub-license for Tubercin.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.